Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively

Tao, H; Liu, Z; Mu, J; Gai, F; Huang, Z; Shi, L

Shi, L (通讯作者),Capital Med Univ, Dept Oncol, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China.

DIAGNOSTIC PATHOLOGY, 2022; 17 (1):

Abstract

Introduction Anaplastic lymphoma kinase (ALK) gene rearrangements, have been identified in approximately 2-7% of patients with lung adenocarcinoma (LU......

Full Text Link